uniQure N.V. Up to $150,000,000 of Ordinary Shares (nominal value €0.05 per share) SALES AGREEMENTSales Agreement • March 2nd, 2020 • uniQure N.V. • Pharmaceutical preparations • New York
Contract Type FiledMarch 2nd, 2020 Company Industry JurisdictionuniQure N.V., a Dutch public company with limited liability (naamloze vennootschap) (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC (“Leerink”), as follows: